Oncology Studies Found: 19,943
Trial Name
Trial ID
Organization
Conditions
Status
Eligibility
Location
Action
Sintilimab Plus Bevacizumab Biosimilar With or Without HAIC for Advanced Hepatocellular Carcinoma (TASK-03): a Multicenter, Randomized, Phase 2 Study
Fudan University
Hepatocellular Carcinoma (HCC)
Recruiting
18 Years
ALL
Shanghai
A Randomized Controlled Trial of Laparoscopic Versus Open Surgery for Colon Cancer With Visceral Obesity
Second Affiliated Hospital, Zhejiang University, School of Medicine
Colonic Neoplasms
Recruiting
18 Years
ALL
Hangzhou
Iceland Screens Treats or Prevents Multiple Myeloma (iStopMM): A Nationwide Phase 2 Trial of Patients With Smoldering and Active Multiple Myeloma (MM)
Landspitali University Hospital
Multiple Myeloma
+1
Enrolling By Invitation
18 Years
ALL
Reykjavik
An Single-arm, Multicenter Phase I/II Clinical Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravesical Instiliations of Disitamab Vedotin in Patients With High-risk Non-muscular Invasive Bladder Cancer (NMIBC) That Express HER2
RemeGen Co., Ltd.
High-risk Non-muscle Invasive Bladder Cancer
Recruiting
18 Years
ALL
Guangzhou
+5
A Single-Arm Phase II Study of Personalized Dose Guidance for Stereotactic Body Radiotherapy (SBRT) in Patients With Lung Tumors
Northwestern University
Lung Carcinoma
+5
Recruiting
18 Years
ALL
Chicago
First-in-human Phase 1a/b, Open-Label, Multicenter, Dose Escalation, Optimization and Expansion Study of ISM5939 in Patients With Advanced and/or Metastatic Solid Tumors
InSilico Medicine Hong Kong Limited
Advanced Solid Tumor
+2
Not Yet Recruiting
18 Years
ALL
Global / TBD
ZSDT for the Treatment of Recurrent Refractory Mantle Cell Lymphoma After BTK Inhibitor Failure: a Multi-center Prospective Clinical Trial
Zhengzhou University
Mantle Cell Lymphoma (MCL)
Not Yet Recruiting
18 Years
ALL
Zhengzhou
First-in-human, Open-label, Phase 1 Trial to Evaluate the Safety and Preliminary Efficacy of GEN1079 in Participants With Select Advanced Malignant Solid Tumors
Genmab
Advanced Solid Tumors
Recruiting
18 Years
ALL
New Haven
+11
Efficacy and Safety of SKB264 Plus Anlotinib in EGFR-TKI-Resistant Advanced NSCLC With Liver Metastasis
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Non-small Cell Lung Cancer
+1
Not Yet Recruiting
18 Years
ALL
Yiwu
A Phase I Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Antitumor Efficacy of LNF2105 in Patients With Advanced Solid Tumors.
Shandong New Time Pharmaceutical Co., LTD
Patients With Advanced Solid Tumors
Not Yet Recruiting
18 Years
ALL
Global / TBD
Page 1
Advanced Trial Filters
Geographic Focus
Trial Phase
Funder / Sponsor Class
Intervention Type
Study Data
Important Notice: Trial data is sourced from ClinicalTrials.gov. While we strive for complete accuracy, this database may not capture every available oncology trial due to indexing variations at the source. This information is not a substitute for professional medical advice. Always consult your healthcare provider regarding treatment options.
Frequently Asked Questions
Where does this clinical trial data come from?
All data displayed on this dashboard is pulled in real-time from ClinicalTrials.gov, a comprehensive database of privately and publicly funded clinical studies conducted around the world, maintained by the U.S. National Library of Medicine.
Why might a specific trial not appear in my search?
Our system uses advanced medical subject headings (MeSH) to find oncology trials. However, if a trial sponsor used highly specific or unconventional terminology when registering their study, it might occasionally be missed. Additionally, newly registered trials may take a few days to appear in the public database.
What do the different “Trial Statuses” mean?
- Recruiting: The trial is currently open and actively accepting new patients.
- Not Yet Recruiting: The trial has been approved but is not yet ready to accept patients.
- Active, Not Recruiting: The trial is ongoing, but it has already enrolled enough participants and is closed to new applicants.
- Completed: The trial has finished, and participants are no longer being treated or examined.
Can I save trials to look at later?
Yes! You can click the “Save” icon next to any trial to save it to your personal list. You can view all your saved trials by clicking the “Saved” button at the top of the dashboard. Please note that saved trials are stored locally on your device; clearing your browser cache will erase your saved list.
How do I contact a trial coordinator?
To find contact information, click the “Eye” icon to view the trial details, then navigate to the “Contacts” tab. If contact details are publicly listed by the trial sponsor, you will find phone numbers and email addresses there. You can click these links to immediately start a call or draft an email.
Is it safe to participate in a clinical trial?
Clinical trials follow strict scientific and ethical guidelines to protect patients. However, all medical treatments carry some level of risk. It is crucial to thoroughly discuss the potential risks and benefits with your primary oncologist before enrolling in any study.